Text Size

Racial and ethnic differences in myopia progression in a large, diverse cohort of pediatric patients

Luong T.Q., Shu Y.-H., Modjtahedi B.S., Fong D.S., Choudry N., Tanaka Y., Nau C.L.


  • 2020
  • Investigative Ophthalmology and Visual Science
View publication
  • Therapeutic Area

    Other

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Southern California Permanente Medical Group, Pasadena, CA, United States; Southern California Permanente Medical Group, Irwindale, CA, United States; Santen Canada, Toronto, ON, Canada; Santen Inc., Emeryville, CA, United States

Related Publications

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Kempen J.H.; Newcomb C.W.; Washington T.L.; Foster C.S.; Sobrin L.; Thorne J.E.; Jabs D.A.; Suhler E.B.; Rosenbaum J.T.; Sen H.N.; Levy-Clarke G.A.; Nussenblatt R.B.; Bhatt N.P.; Lowder C.Y.; Goldstein D.A.; Leiderman Y.I.; Acharya N.R.; Holland G.N.; Read R.W.; Dunn J.P.; Dreger K.A.; Artornsombudh P.; Begum H.A.; Fitzgerald T.D.; Kothari S.; Payal A.R.; Daniel E.; Gangaputra S.S.; Kaçmaz R.O.; Liesegang T.L.; Pujari S.S.; Khachatryan N.; Maghsoudlou A.; Suga H.K.; Pak C.M.; Helzlsouer K.J.; Buchanich J.M.


Exploring Cell-Penetrating Peptides as Penetration Enhancers in Eye Drop Formulations Using a Reconstructed Human Corneal Epithelial Model

Morofuji R.; Enomoto H.; Honda T.; Oyama Y.; Ishida R.; Kudo K.; Okabe K.


Usability of an Eye Drop Delivery Aid for Single-Dose Instillation: Results from a Market Research Study

Lebrón Gutiérrez K.; Thomas S.; Martin J.L.; Dahlmann-Noor A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022